Kalehua Capital Management LLC
Filing Date
Global Rank
#7,026
/ 8,795
▼ 303
· as of Jun 2026
Top Industry
Biotechnology
91.8%
Period ended 3 months ago
Filed Aug 19, 2026 · 48d
3 quarters · since Dec 2025
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
26 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
15.7%
−2.2 pts
Top 5
49.5%
−0.1 pts
Top 10
73.1%
+0.5 pts
HHI
730
Diversified−31
Portfolio Trend
3 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 84.3% | $141,882,611 |
| Unclassified | 15.7% | $26,484,352 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
3 positions
New Positions
Positions the filer opened this quarter
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | 685,644 | $6,698,741 | |
| IFRX | InflaRx N.V. | 2,897,769 | $6,491,002 | |
| ANL | Adlai Nortye Group Ltd. | 226,415 | $2,603,772 | |
| NVCT | Nuvectis Pharma, Inc. | 100,000 | $1,839,000 | |
| MIST | Milestone Pharmaceuticals Inc. | 1,269,237 | $1,700,777 | |
| ATYR | aTYR PHARMA INC | 1,788,167 | $1,067,535 | |
| TCRX | TScan Therapeutics, Inc. | 454,876 | $445,778 | |
| KRSA | Korsana Biosciences, Inc. | 1,651,350 | $0 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| RLAY | Relay Therapeutics, Inc. | 901,457 | $8,969,497 | |
| ORKA | Oruka Therapeutics, Inc. | 118,524 | $5,813,602 | |
| PEPG | PepGen Inc. | 1,000,000 | $1,770,000 | |
| TNYA | Tenaya Therapeutics, Inc. | 2,000,000 | $1,384,000 | |
| KLRS | Kalaris Therapeutics, Inc. | 135,585 | $782,325 | |
| LOOP | Loop Industries, Inc. | 347,539 | $496,980 | |
| DMAC | DiaMedica Therapeutics Inc. | 62,488 | $423,043 | |
| No positions match the current search. | ||||
26 tracked positions ·
$168,366,963 total
· filing declares
26 positions · $173,960,282
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AAAA |
Amplius Aggressive Asset Allocation ETF
|
Added | 226,188 | $26,484,352 | 15.73% | |
| MANE |
Veradermics, Inc
Healthcare
|
Held | 145,695 | $17,911,743 | 10.64% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Held | 3,722,840 | $17,385,662 | 10.33% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Held | 819,692 | $11,598,641 | 6.89% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Held | 385,178 | $9,995,369 | 5.94% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Held | 1,832,365 | $9,693,210 | 5.76% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Held | 197,072 | $8,669,197 | 5.15% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Held | 3,821,890 | $7,758,436 | 4.61% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 198,772 | $6,873,535 | 4.08% | |
| KPTI |
Karyopharm Therapeutics Inc.
Healthcare
|
NEW | 685,644 | $6,698,741 | 3.98% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 194,544 | $6,515,278 | 3.87% | |
| IFRX |
InflaRx N.V.
Healthcare
|
NEW | 2,897,769 | $6,491,002 | 3.86% | |
| KRRO |
Korro Bio, Inc.
Healthcare
|
Added | 405,040 | $5,338,427 | 3.17% | |
| QURE |
uniQure N.V.
Healthcare
|
Reduced | 79,407 | $3,657,486 | 2.17% | |
| LONA |
LeonaBio, Inc.
Healthcare
|
Held | 393,701 | $3,618,112 | 2.15% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
Held | 139,000 | $3,615,390 | 2.15% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Held | 175,734 | $3,421,540 | 2.03% | |
| ANL |
Adlai Nortye Group Ltd.
Healthcare
|
NEW | 226,415 | $2,603,772 | 1.55% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 74,465 | $2,378,412 | 1.41% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
Added | 11,149,363 | $1,839,644 | 1.09% | |
| NVCT |
Nuvectis Pharma, Inc.
Healthcare
|
NEW | 100,000 | $1,839,000 | 1.09% | |
| MIST |
Milestone Pharmaceuticals Inc.
Healthcare
|
NEW | 1,269,237 | $1,700,777 | 1.01% | |
| ATYR |
aTYR PHARMA INC
Healthcare
|
NEW | 1,788,167 | $1,067,535 | 0.63% | |
| TIL |
Instil Bio, Inc.
Healthcare
|
Reduced | 99,600 | $765,924 | 0.45% | |
| TCRX |
TScan Therapeutics, Inc.
Healthcare
|
NEW | 454,876 | $445,778 | 0.26% | |
| KRSA |
Korsana Biosciences, Inc.
Healthcare
|
NEW | 1,651,350 | $0 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.